Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Raytheon Company (NYSE: RTN) unveiled its second generation Exoskeleton (XOS 2) at its research facility in Salt Lake City, Utah, during a demonstration with Paramount Home Entertainment. The new robotic suit is lighter, faster and stronger than its predecessor, yet it uses 50 percent less power. Its enhanced design also means that it is more resistant to the environment.
To view Multimedia NewsRelease, go to http://multivu.prnewswire.com/mnr/raytheon/46273/
Reinforcing its long-standing commitment to furthering math and science education globally, Raytheon Company (NYSE: RTN) is bringing its MathMovesU® initiative to the Gulf Region. Raytheon will premiere the regional expansion of MathMovesU — which is well established in the United States, Australia and Europe — with two key launches.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63761-raytheon-mathmovesu-education-launches-in-gulf-region
Bestselling author Catherynne M. Valente (The Girl Who Circumnavigated Fairyland in a Ship of Her Own Making etc) returns to adult fiction with an eagerly awaited new novel: RADIANCE. She applies the phenomenal talent that made the Fairyland series so popular to give readers what she describes as a decopunk pulp science fiction alt-history space opera mystery set in a Hollywood—and solar system—very different from our own. http://www.catherynnemvalente.com YA, Fantasy, SciFi
A short Clip from: BBC's Horizon Special Psychedelic Experience
One would not expect Britain's traditionally conservative and oft-staid BBC to screen a 50 minute film on the new wave of psychedelic research in humans. Yet, astonishingly enough, such a state of affairs recently came to pass. Before it aired on February 27th, 1997, Psychedelic Science was heavily featured in the media, even getting elaborate treatment in the Radio Times, a mass publication as institutionalised as the BBC itself. The Times, the Guardian, and the Independent, Britain's three leading broadsheets, all carried major pieces announcing the film.
Dr. Deborah Mash and her research with ibogaine was also treated in depth in the film. Mash explains how ibogaine can be used to break cocaine habits although, as with ayahuasca, we do not not learn much about the actual phenomenology induced by ibogaine - suffice it to say that patients experience transformative insights into themselves which can break their patterns of addiction.
Some addicts may have a long history of ADHD
btw
The history of ADHD
http://adhd-npf.com/english-adhd-history-1798-alexander/
is not so new... and many addicts seems to have some of it...
http://adhd-npf.com/history-of-adhd-1902-sir-george/
Extending its award-winning “Learn the Signs” campaign, Autism Speaks – the world’s leading autism science and advocacy organization – today joined the Ad Council, along with partner agencies BBDO New York and LatinWorks, to announce the launch of a new series of public service advertisements (PSAs) designed to reach African American and Hispanic parents. According to research, children in these communities are often diagnosed later than the average. The PSAs, which are being distributed to media outlets nationwide this week, show some of the early signs of autism and encourage parents to take immediate action if their child is not meeting standard developmental milestones.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61698-ad-council-and-autism-speaks-launch-psa-campaign
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The Google Science Fair is the premier online global science competition for students. Students ages 13-18 are invited to submit the most interesting, creative projects for a chance to win scholarships, job opportunities, and once in a lifetime opportunities with the world’s foremost leaders in science and technology. Registration ends April 4th, 2011. Visit http://www.google.com/sciencefair for more info.
Potash Corporation of Saskatchewan Inc. (“PotashCorp”) today launched potashcorp-eKonomics.com, a new online resource that delivers easy-to-understand analyses of soil science data, agronomic information, research and best management practices to help farmers achieve greater financial success. As part of a larger campaign, the site aims to educate farmers about the benefits fertilizer – specifically potash – can deliver to their bottom line.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61611-potashcorp-launches-ekonomics-business-of-soil-fertility
Nearly 200 years after the introduction of the stethoscope, the accuracy of a pocket ultrasound device that enables a physician to “look” at a patient’s heart during routine physical exams has been validated for the first time in peer-reviewed research led by Scripps Translational Science Institute (STSI) and Scripps Health.
Roughly the size of a smart phone, the Vscan™ pocket ultrasound used for point of care assessment of heart health could significantly reduce costs from traditional echocardiograms and improve the quality of care. Research was published in the July 5 issue of the Annals of Internal Medicine.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50963-vscan-pocket-ultrasound-echocardiogram-stethoscope
The Smithsonian’s Lemelson Center for the Study of Invention and Innovation will open its first permanent public home—the Lemelson Hall of Invention and Innovation—at the National Museum of American History July 1. The Hall will feature “Places of Invention,” a signature 3,500 square-foot exhibition examining hotspots of invention throughout history; Draper Spark!Lab, a hands-on space for children aged 6 to 12; and “Inventive Minds,” a small gallery that will introduce the work of the Lemelson Center.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7552051-smithsonian-lemelson-hall-invention-innovation/
Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, today announces a significant advancement in sleep therapy with the commercial release of a first of its kind minimal contact nasal mask – Wisp. Designed to fit more than 98% of sleep apnea patients, Wisp brings distinctive styling and patented technology for a better overall mask experience that may improve patient compliance.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62230-philips-respironics-announces-advancement-in-sleep-therapy-with-wisp
